Hirokazu Iso

2PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Mar 24, 2025
Clinical Impact of Osimertinib Dose Reduction in the First-Line Setting on EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Retrospective Monocentric Study.

Hirokazu Iso, Makiko Yomota, Yukari Shirakura

|Jun 29, 2023
Remarkable Clinical Response of ALK-Rearranged/TP53-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report.

Hirokazu Iso, Akihiko Miyanaga, Naohiro Kadoma

Pageof 1

Frequent Collaborators

1 joint publications

Akihiko Miyanaga

1 joint publications

Takehiro Tozuka

1 joint publications

Yasuhiro Terasaki

1 joint publications

Shoko Kawai